Welcome to our dedicated page for Sensata Tech SEC filings (Ticker: ST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Finding the automotive versus industrial margins hidden deep in Sensata Technologies’ footnotes can take hours. Add in cross-border tax notes, raw-material risk tables, and acquisition earn-outs, and even seasoned analysts struggle to keep pace. That complexity is exactly why we built this page.
Our platform ingests every submission the moment it hits EDGAR and delivers AI-powered summaries that turn dense prose into plain language. Whether you need the Sensata Technologies quarterly earnings report 10-Q filing or want to watch Sensata Technologies Form 4 insider transactions real-time, the latest document is here—already decoded. Use our tools to see:
- Sensata Technologies insider trading Form 4 transactions mapped against product-line announcements
- Sensata Technologies proxy statement executive compensation without digging through exhibits
- Sensata Technologies 8-K material events explained in concise bullet points
Each filing type delivers different insights, and we connect them to what matters for this sensor leader. The Sensata Technologies annual report 10-K simplified highlights segment demand drivers, while our Sensata Technologies earnings report filing analysis flags quarter-over-quarter shifts in OEM orders. Need just the insider angle? Track Sensata Technologies executive stock transactions Form 4 before they hit the news.
If you are understanding Sensata Technologies SEC documents with AI for the first time or benchmarking seasoned positions, our expert analysis, real-time alerts, and comprehensive coverage mean fewer spreadsheets and faster decisions.
ArriVent BioPharma, Inc. (Nasdaq: AVBP) has launched a follow-on public offering consisting of 2,482,692 shares of common stock and pre-funded warrants for up to 1,363,469 additional shares. The securities are priced at $19.50 per share (warrant price $19.4999; exercise price $0.0001).
The base deal will generate $75.0 million in gross proceeds. After underwriting fees of 6 % ($1.17 per share) and estimated expenses, net proceeds are expected to be $69.8 million. Underwriters hold a 30-day option for 576,923 extra shares that would lift gross proceeds to $86.3 million and net proceeds to roughly $80.4 million. The financing increases shares outstanding to 36.5 million (37.1 million if the option is exercised) before any warrant conversion.
Use of proceeds: funds will support clinical development of lead EGFR inhibitor firmonertinib, advance other oncology pipeline programs, and provide general working capital.
Clinical backdrop: Firmonertinib holds FDA Breakthrough Therapy and Orphan Drug designations. Interim data show 79 % ORR in EGFR exon-20 NSCLC (FAVOUR) and 68 % ORR at a 240 mg dose in PACC mutations (FURTHER), with favourable CNS activity and no Grade 4/5 TRAEs. A global Phase 3 PACC study (ALPACCA – FURMO-006) is scheduled to begin 2H 2025.
Capital structure impacts: investors will see an immediate book-value dilution of $12.32 per share. Additional dilution is possible from 4.1 million outstanding stock options (WAEP $14.96), 3.8 million shares reserved for future awards, 3.4 million shares already sold under an at-the-market facility, and any exercise of the new pre-funded warrants. ArriVent also owes up to $765 million in milestones to its partner Shanghai Allist for global rights to firmonertinib.
Key terms of the pre-funded warrants: no expiration, exercisable any time for $0.0001 per share, subject to 4.99 %/9.99 % beneficial-ownership caps, and will not be listed for trading.
Timeline: closing and delivery are expected on or about 3 July 2025.
FAQ
What is the current stock price of Sensata Tech (ST)?
What is the market cap of Sensata Tech (ST)?
What is the core business of Sensata Technologies?
Which industries benefit from Sensata's products?
How does Sensata generate its revenue?
What makes Sensata's products unique in the market?
How does Sensata maintain its industry expertise?
How does Sensata cater to regional market needs?
How is Sensata positioned within the competitive landscape?
What are the key factors behind Sensata's market significance?
